FDA Approves AbbVie’s Once-Daily Parkinson’s Drug Tavapadon
WASHINGTON: (News Desk) - The US Food and Drug Administration has approved AbbVie’s tavapadon treatment for adults with Parkinson’s disease, according to information posted on the regulator’s website Friday.
The drug, which will be…